CP-1C is an investigational GLP-1/amylin receptor combination compound for laboratory research involving incretin and amylin pathway signaling.
Research compound – for laboratory use only.
$39.50 – $803.25Price range: $39.50 through $803.25
Long-acting amylin analog studied in metabolic pathway research alongside GLP-1 receptor signaling. CP-1C is currently mixed-batch: the 5mg strength remains Batch 001 with prior verified documentation, and the 10mg strength is Batch 002 with third-party analytical testing in progress. For research use only - not for human consumption.
CP-1C is an investigational GLP-1/amylin receptor combination compound for laboratory research involving incretin and amylin pathway signaling.
Research compound – for laboratory use only.
| Weight | 0.94 oz |
|---|---|
| Strength | 5mg, 10mg |
| pack-size | Single vial, 10-vial kit |
Longevity Research, Metabolic Research
$63.00 – $833.85Price range: $63.00 through $833.85 This product has multiple variants. The options may be chosen on the product page Quick View